RECOVERY & REPAIR STACK
Stronger Together
These recovery blends aren't competing options—they build on each other. Each step adds a layer of research focus, from a foundation of tissue repair to full-spectrum regeneration. Here's how the stack layers up.
THE PROGRESSION
Three steps, building on one foundation
Each blend contains the one before it, plus an added component that expands its research focus. Explore any layer for its full Evidence Snapshot.
Start with the foundation of deep healing and recovery. BPC-157 and TB-500 are studied together to reduce inflammation, repair tissue, and support healing from the inside out.
Its role in the stack
Builds the foundation every other layer rests on—repair both at the injury site and body-wide.
Add GHK-Cu to amplify beauty, collagen, and deeper repair. GHK-Cu takes the foundation further—stimulating collagen, elastin, and regenerative pathways for visible cosmetic benefits alongside tissue repair.
What it adds
Builds on the foundation with GHK-Cu's cosmetic and collagen-boosting benefits.
Add KPV to complete the stack with anti-inflammatory power. KPV brings anti-inflammatory and immune-balancing effects—completing the stack for full-spectrum regeneration and long-term tissue health.
What it completes
Adds KPV's inflammation control and immune balance for total regeneration.
WHAT'S IN EACH DOSE
The per-dose breakdown
Here is what one typical research draw contains of each component. These figures assume the standard reconstitution: 20mg in 2mL for the foundation, 70mg and 80mg in 3mL for GLOW and KLOW.
| Component | Foundation “WOLV” — 6 units | GLOW — 10 units | KLOW — 10 units |
|---|---|---|---|
| BPC-157 | 300mcg | ~333mcg | ~333mcg |
| TB-500 | 300mcg | ~333mcg | ~333mcg |
| GHK-Cu | — | ~1.67mg | ~1.67mg |
| KPV | — | — | ~333mcg |
| Total peptide per draw | 600mcg | ~2.33mg | ~2.67mg |
The Math Is 1/30th
A 10-unit draw (0.1mL) takes 1/30th of a 3mL vial—so each component's per-draw amount is its vial amount divided by 30. GLOW is 50mg GHK-Cu + 10mg TB-500 + 10mg BPC-157; KLOW adds 10mg KPV.
Foundation Carried Forward
Every layer delivers a full foundation-level draw of BPC-157 and TB-500—stepping up to GLOW or KLOW doesn't dilute the repair pair, it builds on it.
Component Targets
KLOW's ~333mcg of KPV sits inside KPV's standalone 250–500mcg research range; GHK-Cu at ~1.67mg runs slightly under its standalone 2mg daily target.
Values describe laboratory research parameters only; a 10-unit draw on a U-100 syringe is 0.1mL. Reconstitution amounts and vial durations for every compound are in the research reference table.
WHY RESEARCHERS STACK THEM
One foundation, layered focus
Multiple Pathways
Each layer targets a different research pathway—repair, then cosmetic regeneration, then inflammation control.
Builds Progressively
Each blend contains the previous one, so the research focus expands rather than changes.
Transparent Maturity
Evidence maturity is shown honestly for each layer—from the Experimental foundation to the Emerging blends.
How to read this comparison
These are combination research blends. Descriptions reflect the studied research focus of each component, not effect promises or guaranteed outcomes. As combinations, the specific blends are not trial-tested—see each compound page for its full Evidence Snapshot, including how blend evidence is scored. All materials are offered strictly for laboratory and research use.